GCS-100
- Generic Name
- GCS-100
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 3HO3IZ2ILX
- Associated Conditions
- -
- Associated Therapies
- -
A Phase 2 Extension of Study GCS-100-CS-4003
- First Posted Date
- 2015-01-08
- Last Posted Date
- 2015-01-15
- Lead Sponsor
- La Jolla Pharmaceutical Company
- Registration Number
- NCT02333955
- Locations
- 🇺🇸
California Institute of Renal Research, La Mesa, California, United States
🇺🇸Southwest Clinical Research Institute, LLC, Tempe, Arizona, United States
🇺🇸Denver Nephrology, Denver, Colorado, United States
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2015-05-19
- Lead Sponsor
- La Jolla Pharmaceutical Company
- Target Recruit Count
- 375
- Registration Number
- NCT02312050
- Locations
- 🇺🇸
Southeast Renal Research Institute, Chattanooga, Tennessee, United States
🇺🇸Clinical Advancement Center, San Antonio, Texas, United States
🇺🇸Mountain Kidney & Hypertension, Asheville, North Carolina, United States
A Phase 2 Extension Study of Study GCS-100-CS-4002
- First Posted Date
- 2014-06-04
- Last Posted Date
- 2016-12-26
- Lead Sponsor
- La Jolla Pharmaceutical Company
- Target Recruit Count
- 92
- Registration Number
- NCT02155673
- Locations
- 🇺🇸
California Institute of Renal Research, La Mesa, California, United States
🇺🇸Denver Nephrology, Denver, Colorado, United States
🇺🇸Mountain Kidney and Hypertension Associates, PA, Asheville, North Carolina, United States
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2015-09-01
- Lead Sponsor
- La Jolla Pharmaceutical Company
- Target Recruit Count
- 120
- Registration Number
- NCT01843790
- Locations
- 🇺🇸
Denver Nephrology, Denver, Colorado, United States
🇺🇸Southwest Clinical Research Institute, LLC, Tempe, Arizona, United States
🇺🇸California Institute of Renal Research, La Mesa, California, United States
Safety Study of GCS-100 to Treat Chronic Kidney Disease
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- La Jolla Pharmaceutical Company
- Target Recruit Count
- 29
- Registration Number
- NCT01717248
- Locations
- 🇺🇸
Denver Nephrologists, PC, Denver, Colorado, United States
🇺🇸Renal Associates PA / Research Division, San Antonio, Texas, United States
🇺🇸California Institue of Renal Research, La Mesa, California, United States
GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2008-10-21
- Last Posted Date
- 2013-06-25
- Lead Sponsor
- La Jolla Pharmaceutical Company
- Registration Number
- NCT00776802
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2013-06-25
- Lead Sponsor
- La Jolla Pharmaceutical Company
- Target Recruit Count
- 9
- Registration Number
- NCT00609817
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Froedtert & Medical College Clinics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸University of Florida, Gainesville, Florida, United States
Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
- First Posted Date
- 2007-08-10
- Last Posted Date
- 2013-06-17
- Lead Sponsor
- La Jolla Pharmaceutical Company
- Target Recruit Count
- 12
- Registration Number
- NCT00514696
- Locations
- 🇺🇸
Dayton Oncology & Hematology, Kettering, Ohio, United States
🇺🇸Rocky Mountain Cancer Centers, Denver, Colorado, United States
🇺🇸Tyler Cancer Center, Tyler, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.